CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells

被引:69
作者
Marschner, A
Rothenfusser, S
Hornung, V
Prell, D
Krug, A
Kerkmann, M
Wellisch, D
Poeck, H
Greinacher, A
Giese, T
Endres, S
Hartmann, G
机构
[1] Univ Munich, Med Klin Innenstadt, Div Clin Pharmacol, Dept Internal Med, D-80336 Munich, Germany
[2] Heidelberg Univ, Inst Immunol, D-6900 Heidelberg, Germany
[3] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany
关键词
CpG oligonucleotide; NKT cells; plasmacytoid dendritic cell; myeloid dendritic cell; type I interferon;
D O I
10.1002/eji.200425721
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human V alpha 24(+) V beta 11(+) natural killer T cells (NKT cells) are "natural memory" T cells that detect glycolipid antigens such as alpha-galactosylceramide (alpha-GalCer) presented on CD1d. In the present study we found that highly purified V alpha 24(+) NKT cells lack TLR9 mRNA, and thus are not sensitive towards stimulation with CpG oligodeoxynucleotides (ODN). Within PBMC, however, CpG ODN synergistically activated NKT cells stimulated with their cognate antigen alpha-GalCer. Depletion of plasmacytoid dendritic cells (PDC) or myeloid dendritic cells (MDC) revealed that both DC subsets were necessary for the synergistic activation of NKT cells by alpha-GalCer and CpG ODN. While PDC were responsible for the stimulation of NKT cells with CpG ODN, MDC but not PDC presented alpha-GalCer via CD1d. Partial activation of NKT cells was mediated by PDC-derived IFN-alpha, whereas full activation of NKT cells as indicated by IFN-gamma production required cell-to-cell contact of PDC and NKT cells in addition to IFN-alpha; OX40 was involved in this interaction. We conclude that CpG-activated PDC enhance alpha-GalCer-specific NKT cell activation, and bias activated NKT cells towards a Thl phenotype. Our results lead to a novel concept of PDC function: to regulate effector activity of antigen-stimulated T cells in a cell contact-dependent manner without the need of simultaneous presentation of the cognate T cell antigen.
引用
收藏
页码:2347 / 2357
页数:11
相关论文
共 72 条
[1]   Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls [J].
Apostolou, I ;
Takahama, Y ;
Belmant, C ;
Kawano, T ;
Huerre, M ;
Marchal, G ;
Cui, J ;
Taniguchi, M ;
Nakauchi, H ;
Fournié, JJ ;
Kourilsky, P ;
Gachelin, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) :5141-5146
[2]   Costimulation of CD8 T cell responses by OX40 [J].
Bansal-Pakala, P ;
Halteman, BS ;
Cheng, MHY ;
Croft, M .
JOURNAL OF IMMUNOLOGY, 2004, 172 (08) :4821-4825
[3]   Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].
Bauer, S ;
Kirschning, CJ ;
Häcker, H ;
Redecke, V ;
Hausmann, S ;
Akira, S ;
Wagner, H ;
Lipford, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242
[4]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[5]   NK cells and NKT cells in innate defense against viral infections [J].
Biron, CA ;
Brossay, L .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (04) :458-464
[6]   CD1: Antigen presentation and T cell function [J].
Brigl, M ;
Brenner, MB .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :817-890
[7]   CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution [J].
Brossay, L ;
Chioda, M ;
Burdin, N ;
Koezuka, Y ;
Casorati, G ;
Dellabona, P ;
Kronenberg, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1521-1528
[8]  
Carnaud C, 1999, J IMMUNOL, V163, P4647
[9]   Requirement for V(alpha)14 NKT cells in IL-12-mediated rejection of tumors [J].
Cui, JQ ;
Shin, T ;
Kawano, T ;
Sato, H ;
Kondo, E ;
Toura, I ;
Kaneko, Y ;
Koseki, H ;
Kanno, M ;
Taniguchi, M .
SCIENCE, 1997, 278 (5343) :1623-1626
[10]   CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans [J].
Davis, HL ;
Suparto, I ;
Weeratna, R ;
Jumintarto ;
Iskandriati, D ;
Chamzah, S ;
Ma'ruf, A ;
Nente, C ;
Pawitri, D ;
Krieg, AM ;
Heriyanto ;
Smits, W ;
Sajuthi, D .
VACCINE, 2000, 18 (18) :1920-1924